In Reply We thank Miguel et al for their response to our article1 documenting the outcome of children with hypoxic ischemic encephalopathy (HIE) at 18 to 42 months, in which we showed that the cognitive abilities of children with a history of mild HIE were significantly lower than those of healthy control children.
Miguel et al highlight their work,2 which examined inherited differences in the dopamine transporter gene (DAT1) function and their effect on cognitive flexibility measured at 4 to 6 years of age. Polymorphisms in the DAT1 gene have been repeatedly associated with attention deficient disorder.3 In their study,2 healthy children from 2 birth cohorts were divided into those with a high expression–based polygenic risk score (ePRS) and those with a low ePRS. They report that, in these cohorts, DAT1 expression remained stable over time and was associated with regional gray matter density.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Murray DM, Finder M, Boylan GB. Neonatal Hypoxia Ischaemia and Individual Differences in Neurodevelopmental Outcomes—Reply. JAMA Pediatr. 2020;174(8):803–804. doi:10.1001/jamapediatrics.2020.0546
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: